PRAC anticorps (N-Term)
Aperçu rapide pour PRAC anticorps (N-Term) (ABIN926529)
Antigène
Voir toutes PRAC AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
-
-
Épitope
- N-Term
-
Purification
- Purified
-
Immunogène
- PRAC antibody was raised in rabbit using the N terminal of PRAC as the immunogen
-
-
-
-
Indications d'application
- Optimal conditions should be determined by the investigator.
-
Commentaires
-
PRAC Blocking Peptide, (ABIN937516), is also available for use as a blocking control in assays to test for specificity of this PRAC antibody
-
Restrictions
- For Research Use only
-
-
-
Format
- Lyophilized
-
Concentration
- Lot specific
-
Buffer
- Lyophilized powder. Add 50 µL of distilled water. Final antibody concentration is 1 mg/mL in PBS buffer.
-
Conseil sur la manipulation
- Avoid repeated freeze/thaw cycles.
-
Stock
- 4 °C/-20 °C
-
Stockage commentaire
- Store at 4 °C, following reconstitution, aliquot and store at -20 °C.
-
-
- PRAC (Prostate Cancer Susceptibility Candidate (PRAC))
-
Autre désignation
- PRAC
-
Sujet
- This gene is reported to be specifically expressed in prostate, rectum and distal colon. Sequence analysis suggests that it may play a regulatory role in the nucleus. Synonyms: Polyclonal PRAC antibody, Anti-PRAC antibody, prostate cancer susceptibility candidate antibody, C17orf92 antibody, MGC32520 antibody.
Antigène
-